Skip to search formSkip to main contentSkip to account menu

Checkpoint Kinase Inhibitor AZD7762

A synthetic small molecule inhibitor of checkpoint kinases (Chks) with potential chemosensitizing activity. AZD7762 binds to and inhibits Chks, which… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BackgroundAZD7762 is a checkpoint kinase 1 (Chk 1) inhibitor, which has been reported to sensitize many tumor cells to DNA damage… 
2018
2018
Purpose: Our aim was to identify predictive factors of abiraterone acetate efficacy and putative new druggable targets in… 
2017
2017
BackgroundMore effective chemotherapies are urgently needed for bladder cancer, a major cause of morbidity and mortality… 
2014
2014
Objective Checkpoint kinase (Chk) inhibitors are thought to increase the cytotoxic effects of DNA-damaging agents and are… 
Highly Cited
2012
Highly Cited
2012
DNA cross-linking agents are frequently used in the treatment of multiple myeloma–generating lesions, which activate checkpoint…